BioConAct
ActiveSummary
BioConAct has been active since 2020 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €44,346 and a net result of €44,246. Equity is growing by about 9% per year across the filed financial years. Its solvency ranks better than 33% of 2,056 sector peers (NACE 73, financial year 2025). The computed 12-month bankruptcy probability is 1.2% (low).
Group and network
Connections & network
The board mandates are listed below; here you explore them as a network.
This company
Company
Director
Shareholding
+N: links not shown yet
Click a node to look further, drag to arrange, zoom with the mouse wheel.
Board mandates elsewhere
1 board mandateBoard mandates of this companythis company sits on their board1
1 location